Media Contacts

Katie Parker, PR/Marketing Director
309.691.6906
kparker@komenmemorial.org

News / Press Releases:

9/29/16 - Susan G. Komen® Funded Research Shows Promise in Slowing, Stopping Metastatic Breast Cancer

FOR IMMEDIATE RELEASE

Local Media Contact: Katie Parker               National Media Contact:    Joni Avery
Susan G. Komen Memorial Affiliate             Susan G. Komen®
(C)309.922.1462 (W) 309.691.6906             972.855.4382
kparker@komenmemorial.org                       press@komen.org

SUSAN G. KOMEN®-FUNDED RESEARCH SHOWS PROMISE IN SLOWING, STOPPING METASTATIC BREAST CANCER

 Work Led by Komen-Funded Young Investigator Reveals More about Role of RAGE in Breast Cancer Metastasis

 DALLAS – September 29, 2016 – A research grant awarded by Susan G. Komen in 2015 is breaking new ground in the understanding of metastatic breast cancer. Dr. Barry I. Hudson, cancer researcher at Sylvester Comprehensive Cancer Center (part of UHealth – the University of Miami Health System), and team found that blocking expression of Receptor for Advanced Glycation End-products (RAGE) in breast cancer cells led to a decrease in the cells’ ability to invade surrounding tissue. They also showed in both human cells and mouse models that blocking RAGE decreased tumor growth and reduced tumor angiogenesis (development of new blood vessels). In addition, blocking RAGE also reduced the recruitment of inflammatory cells and dramatically decreased metastasis to both the lungs and liver in mouse models of breast cancer.

These data demonstrate that RAGE drives tumor progression and metastasis, and may represent a novel target for the development of new therapies for metastatic breast cancer.

“To achieve our organization’s new Bold Goal to decrease the current number of breast cancer deaths by 50 percent in the U.S. over the next decade, we need significant breakthroughs in the treatment of metastatic breast cancer. The work of Dr. Hudson and his team is an important step to take on the form of the disease that claims 40,000 lives annually,” said Komen President and CEO Dr. Judy Salerno.

“These significant findings also underscore the need for continuous support of research funding for young investigators hoping to launch a career in breast cancer research, like Dr. Hudson, who received a Career Catalyst Research grant last year. The next generation of breast cancer researchers will be the ones to bring us the cures, and we must ensure they are able to pursue their work,” Dr. Salerno added.

Komen recently announced $32.7 million in new research funding, nearly 40 percent of which is focused on metastatic research. To date, the organization has invested more than $166 million in over 400 research grants and more than 40 clinical trials focused on metastatic breast cancer.

Read more about the new findings in Oncogene.

9/28/16 - Susan G. Komen® Launches “More Than Pink™” Movement In October Supporting Goal To Cut Current Breast Cancer Deaths In Half

FOR IMMEDIATE RELEASE

Local Media Contact: Katie Parker               National Media Contact:    Dana Fennewald
Susan G. Komen Memorial Affiliate             Susan G. Komen®
(C)309.922.1462 (W) 309.691.6906             972.855.1670
kparker@komenmemorial.org                       dfennewald@komen.org

SUSAN G. KOMEN® LAUNCHES “MORE THAN PINK” MOVEMENT IN OCTOBER SUPPORTING GOAL TO CUT CURRENT BREAST CANCER DEATHS IN HALF

World’s Largest Breast Cancer Organization Partners with Public Figures, Scientists, and Advocates to Highlight Impact, Save More Lives

DALLAS, TX – September 28, 2016 – Pink is important and, if you ask the Susan G. Komen organization, there’s not enough pink as long as 40,000 women and men continue to die each year in the U.S. from breast cancer. However, pink is more than just a color; it represents the impact that each person is making in the fight against the most frequently diagnosed cancer worldwide.

Two weeks ago, Komen announced its new Bold Goal to reduce the current number of breast cancer deaths in the U.S. by 50 percent in the next decade and is now rallying supporters to take the extra step – make a bigger, bolder impact and be More Than Pink.”

The More Than Pink™ movement, kicking off in October (National Breast Cancer Awareness Month), celebrates the heroes who have made a significant impact in the fight to end breast cancer. Whether you’re the doctor who won’t give up on a patient, the volunteer who gives their free time to ensure the Race for the Cure goes off without a hitch, or the child who sells lemonade in honor of his or her mother; More Than Pink will provide the inspiration for everyone to act, donate, and get involved.

“We’ve all witnessed the courageous struggle of someone we love, fighting breast cancer; a friend or co-worker, someone in our family – even ourselves. It’s time to take the next leap forward in the fight against this disease,” says SVP of Marketing Miguel Perez. “More Than Pink is our rallying cry to encourage everyone to step up to the plate – in ways big and small – and become a hero.”

The month kicks off with the launch of “The List” – a group of everyday heroes, scientists, clinicians, advocates, community leaders, athletes, musicians, and public figures who are being honored for their contributions and impact in working for women and men facing breast cancer.

The List honors a wide variety of figures including: Dr. Mary-Claire King (discoverer of the genetic link for increased breast cancer risk); Dr. Craig Jordan (the “Father of Tamoxifen”); former First Ladies Laura Bush and Betty Ford; Princess Dina Mired of Jordan; and celebrities and public figures who have advanced our cause: WWE Superstar John Cena; singer/songwriter Jason Aldean; professional boxing champion Oscar De La Hoya; and everyday heroes such as Allison Titus and Jordan Phillips, young women whose families have been affected by breast cancer and who have raised funds to ensure that no family is affected as they were. The More Than Pink™ movement provides a national platform on which to share their stories and encourage others to join.

The List honorees will be visible this October, spreading the More Than Pink™ message throughout national sporting events, concerts, races, educational webinars, news and talk shows and social media networks, and beyond. Additionally, the stories and faces of a select few of Komen’s “heroes” will be showcased in newly developed public service announcements and advertisements being placed and streamed on a variety of traditional and digital media platforms throughout the country.

Throughout its 35-year history, Susan G. Komen has been fortunate to work with hundreds of renowned partners who share a common passion for providing support and strength for those battling breast cancer. Komen’s corporate partners not only raise funds; they engage hundreds of thousands of employees and millions of customers to learn about breast cancer, take action for their health and support breast cancer research and community programs worldwide.

This year’s More Than Pink movement is being supported specifically by American Airlines, Bank of America, Condé Nast, Simon Property Group, and WWE. Thanks to their commitment and support, consumers around the globe will find More Than Pink™ in many venues – banking at the ATM, shopping at the mall, reading a favorite magazine, sitting back on a flight, or just relaxing at home watching Monday Night Raw.

“Our partners make it possible to fund lifesaving research and help hundreds of thousands of people every year,” says Perez. “This year, with More Than Pink, they are all stepping up, digging deep and getting creative on how to make the biggest impact in our mission to end breast cancer, forever.”

Additionally, Susan G. Komen is tapping in to its network of 100 local Affiliates to extend the More Than Pink™ message to communities throughout the U.S. For those interested in joining the movement on a local level, an entire list of Komen Affiliates can be found by visiting: http://ww5.komen.org/Affiliates.aspx.

Susan G. Komen encourages all supporters to follow a frequent stream of More Than Pink™ hero stories on Facebook, Twitter, and Instagram, and share their More Than Pink™ hero stories on social media using the hashtag #MoreThanPink. Learn how to donate, act and get involved by visiting: komen.org/morethanpink.

 

 SUSAN G. KOMEN MORE THAN PINK, BREAST CANCER, AND ORGANIZATION OVERVIEW

Susan G. Komen Overview

  • Since inception in 1982 Komen has become the world’s largest breast cancer organization, and has funded more than $920 million in research and provided more than $2 billion in funding to screening, education, treatment and psychosocial support programs serving millions of people in the U.S. and more than 30 countries worldwide.
  • This past fiscal year, Komen spent 81 cents of every dollar on our community and research programs, marking the eleventh straight year we spent more than 80% on mission programs.
  • Research is vital, but it is also critical support women and men facing breast cancer NOW. This is why our mission has always included research and funding for a wide variety of other services including free breast screenings, free or low-cost diagnostic services, patient navigation, transportation to/from appointments, treatment assistance, financial support and more.
  • In 2014 (last full year available), Susan G. Komen’s community grants provided:
    • Free or low-cost screening, diagnostic and treatment services for more than 400,000 families impacted by breast cancer.
    • Financial and psychosocial support for more than 15,000 families impacted by breast cancer. (Actual number is 15,061.)
    • Patient navigation for nearly 155,000 families impacted by breast cancer (actual number is 154,838)
    • The total number of services provided in 2014 was 2,232,182 – that includes education, screening, treatment and treatment assistance programs.

More Than Pink

  • More than 40,000 women will lose their lives to breast cancer in the U.S. alone this year. It’s time to change that number, and Susan G. Komen has set a Bold Goal to do so, complemented by a new movement that celebrates those who have made progress possible over our first 34 years.
  • Komen’s recently announced Bold Goal aims to reduce the current number of breast cancer deaths in the U.S. by 50 percent in the next decade. We are now rallying supporters to take the extra step – make a bigger, bolder impact and be “More Than Pink.”
  • The “More Than Pink” movement, kicking off in October (National Breast Cancer Awareness Month), is a series of initiatives that celebrate the heroes who have made a significant impact in the fight to end breast cancer.
  • The More Than Pink movement is supported by American Airlines, Bank of America, Condé Nast, Simon Property Group, and WWE, who together have raised more than $100 million on behalf of Komen since 1982.
  • Komen’s corporate partners not only raise funds – more than $500 million for the cause thus far – they engage hundreds of thousands of employees and millions of customers to learn about breast cancer, take action for their health and support breast cancer research and community programs worldwide.
  • Thanks to Komen’s partner support, consumers will experience More Than Pink in many venues: while banking, at the ATM, shopping at the mall, reading a favorite magazine, sitting back on a flight, or just relaxing at home watching Monday Night Raw.
  • Susan G. Komen also is tapping in to its network of 100 U.S. Affiliates to extend the More Than Pink message to all local communities throughout the U.S. For those interested in joining the movement on a local level, an entire list of Komen Affiliates can be found by visiting: http://ww5.komen.org/Affiliates.aspx.
  • Susan G. Komen encourages all supporters to follow a frequent stream of More Than Pink hero stories on Facebook, Twitter, and Instagram, and share their More Than Pink hero stories on social media using the hashtag #MoreThanPink. Learn how to donate, act, and get involved by visiting: www.komen.org/morethanpink.com.

The List

  • Komen announced an inaugural line-up – “The List” – recognizing scientists, clinicians, advocates, community leaders, athletes, musicians, public figures and “everyday heroes” for their contributions and impact in working towards a cure.
  • The List honors a wide variety of figures including: Dr. Mary-Claire King (discoverer of the genetic link for increased breast cancer risk); Dr. Craig Jordan (the “Father of Tamoxifen”); former First Ladies Laura Bush and Betty Ford; Princess Dina Mired of Jordan; and celebrities and public figures who have advanced our cause: WWE’s John Cena; singer/songwriter Jason Aldean; professional boxing champion Oscar De La Hoya; and everyday heroes such as Allison Titus and Jordan Phillips, young women whose families have been affected by breast cancer and who have raised funds to ensure that no family is affected as they were.
  • Many of The List honorees will be out and about this October, spreading the More Than Pink message at national sporting events, concerts, races, educational webinars, broadcast news and talk shows, social media networks, and beyond.
  • In addition, the stories and faces of a select few of Komen’s “heroes” will be showcased in newly developed public service announcements and advertisements being placed and streamed on a variety of traditional and digital media platforms throughout the country.

Breast Cancer Statistics

United States

  • Except for skin cancers, breast cancer is the most common cancer among women.
  • In 2016, more than 240,000 cases of invasive breast cancer will be diagnosed in women and 2,600 in men.
  • Every 2 minutes, one case of breast cancer is diagnosed in a woman.
  • In 2016, about 40,450 women and 440 men are expected to die from breast cancer in the U.S.
  • Early detection and effective treatment contributed to a 37 percent decline in breast cancer mortality (deaths) between 1990-2013.
  • Currently there are more than 3 million breast cancer survivors.
  • One in 8 women will be diagnosed with breast cancer in her lifetime.

 

Around the World

  • Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death in women, with nearly 1.7 million new cases recorded in 2012.
  • Every 60 seconds, somewhere in the world, someone dies from breast cancer.
  • At the current rate, 13 million breast cancer deaths around the world will occur in the next 25 years.

Partner Information

American Airlines:

As Komen’s longest standing corporate partner, American Airlines, their employees and customers have supported the fight against breast cancer for more than 33 years. American’s current support of our mission includes raising funds to support seven young investigators funded by Susan G. Komen to conduct research into metastatic and triple negative breast cancer. Funds are raised through the Miles for the Cure program, which offers AAdvantage miles to donors for every dollar donated to Komen at komen.org/aa. American also hosts the Celebrity Golf and Tennis event, which has brought together dedicated customers, celebrities and generous sponsors for more than 20 years. American also serves as the National Volunteer Sponsor of the Race for the Cure, providing volunteer support and AAdvantage mileage certificates for fundraising and travel purposes to more than 136 events across the country.

Bank of America:

Bank of America has partnered with and supported Susan G. Komen since 2009. They serve as the National Presenting Sponsor of the Susan G. Komen Race for the Cure® and 3-Day® Series. Bank of America supports Komen through its Pink Ribbon Banking Affinity products, which have raised over $7 million to date to help Komen fund ground breaking breast cancer research and community outreach programs. Employees of Bank of America support Komen across the country by volunteering in their local markets and many executives sit on local Susan G. Komen Board of Directors. Together, we will change the course of breast cancer.

Conde Nast:

Condé Nast has been a passionate, dedicated partner in the fight for over 21 years.  Condé Nast is a media company with 115 million consumers across print, digital and video brands, including titles like Self, Golf Digest, GQ, Vogue, Vanity Fair, Glamour, bon appetit, The New Yorker and more.   This broad reach provides invaluable exposure for Komen’s impact, messages and awareness to millions, and each Race For The Cure® participant is offered a free magazine subscription.  Conde Nast also facilitates the Rally for the Cure® program.  Since 1996, thousands of volunteer led golf, tennis and social Rally for the Cure® events help spread the awareness message to millions of participants while activating their communities, and have raised over $79 million for Komen and its local Affiliates. Through their media messaging, support of both Race For the Cure and Rally For the Cure.

Simon Property Group:

Simon Property Group is making a bold commitment to help Susan G. Komen make an impact in the fight to end breast cancer. Simon is committed to raising crucial funds to help support lifesaving research and community outreach programs while encouraging shoppers and employees to Be More Than Pink by supporting our mission in nearly 200 Simon properties nationwide. The pinnacle of their partnership with Komen is the discount card program. During October, shoppers can make a donation to Komen and receive discounts in the following ways:

  • Donate $10 to Komen at participating Simon Mills and Premium Outlets to receive 25% off one item at all participating retailers
  • Donate $5 or $10 at participating Simon Malls to receive 15-25% off one item at all participating retailers
9/19/16 - Komen Announces Nearly $33 Million in New Research Funding to Support Bold Goal of Cutting Breast Cancer Mortality by 50%

Illinois Researchers Receive $1,260,700 in Research Funding
DALLAS – September 19, 2016 – Building on its bold goal to reduce current breast cancer deaths by 50 percent in the U.S. over the next decade, Susan G. Komen, the world’s leading breast cancer organization, today announced $32.7 million in new research grants for 2016. Awarded across 23 states and 7 countries, the projects span the entire continuum of breast cancer research, including research into metastatic disease, novel treatments for aggressive types of breast cancer, new technologies and health equity – areas that will make a significant impact in achieving the 50 percent goal.

The grants include $1,235,700 in new funding for research at four institutions in Illinois, bringing Komen’s total research investment in Illinois to $19,383,794 since 1982.

“For nearly 35 years our organization has been a leader in the fight to end breast cancer, changing how people think about, talk about and treat this disease. Now, with a sharpened focus on our organization’s new strategic direction, we are delighted to announce new research funding that will play a significant role in making our bold goal a reality,” said Komen President and CEO Judy Salerno, M.D., M.S.

“Not only will these grants accelerate our understanding of key areas in breast cancer research, but they include funding for early-career investigators. As federal research dollars become increasingly difficult to secure, these awards give promising young researchers an opportunity to establish their careers, and help ensure breakthrough breast cancer research continues for years to come,” Dr. Salerno added. “Their work is essential to achieving our vision of a world without breast cancer.”

Grants from Komen’s nearly $33 million 2016 research portfolio* – including more than $16 million to early-career investigators – will focus on promising areas in research that have the greatest potential to save lives, including:

– 38 grants expanding our knowledge of metastatic breast cancer and how to stop it.
– 15 grants looking into novel treatments for aggressive types of breast cancer (specifically, triple negative, Luminal B and inflammatory breast cancer).
– 21 grants advancing our ability to detect primary and recurrent breast cancer at its earliest stages.
– 12 grants identifying the causes of breast cancer disparities and testing ways to overcome barriers to care.

Komen’s Investments in Illinois

Komen’s research program is funded in part by contributions from Komen’s nationwide Network of Affiliates, which direct 25 percent of funds raised locally to Komen’s national research program, while investing the remaining 75 percent into community outreach programs that serve local women and men facing breast cancer.

Since 1992, the Memorial Affiliate has funded over $11 million to community programs serving local women and men, while contributing over $3 million to Komen research.

“We are so thankful for the friends, family and neighbors who fight alongside us, helping to reduce the number of breast cancer deaths in Illinois, both on the ground and through research,” said Linda Maricle, Executive Director.

In Illinois, researchers will receive $1,235,700, including:

The University of Chicago

  • Mary Dolan, Ph.D., will receive $405,000 to create a Graduate Program in Breast Cancer Disparities at the University of Chicago. Master’s and doctoral students will leverage the institution’s strength in health disparities research to conduct research focused on understanding and eliminating breast cancer disparities

Northwestern University-Chicago Campus

  • Dai Horiuchi, Ph.D., will receive $450,000 to investigate a class of cancer drugs called PIM inhibitors, which are currently being used to treat other cancers, as a new targeted therapy against a specific subtype of triple negative breast cancer.

The University of Illinois at Urbana-Champaign

  • Amy Baek, Ph.D., will receive $180,000 to study the process by which a byproduct of cholesterol promotes breast cancer metastasis. Dr. Baek will determine if immune cells are involved, and use this information to develop inhibitors that will block this process and prevent breast cancer metastasis.
    • Abhishek Sharma, Ph.D., will receive $180,000 to develop a drug that targets and blocks mutant estrogen receptors which are more commonly found in endocrine-resistant, metastatic breast cancer. Dr. Sharma’s new drug could be a new option for ER+ breast cancers that have developed resistance to current endocrine-based therapies.

These new funds bring Komen’s total research investment to more than $920 million since opening its doors in 1982, the largest of any nonprofit outside the U.S. government. In addition to research, Komen and its nationwide network of Affiliates serve women and men in thousands of communities. To date, more than $2 billion has been invested in community programs that provide education, screening and treatment support.

*Contingent upon signed and executed contracts with Komen

9/14/16 - Komen Announces $27 Million Health Equity Initiative to Reduce Breast Cancer Deaths in African-American Community

FOR IMMEDIATE RELEASE

Local Media Contact: Katie Parker               National Media Contact:    Andrea Rader
Susan G. Komen Memorial Affiliate             Susan G. Komen®
(C)309.922.1462 (W) 309.691.6906             972.855.4382
kparker@komenmemorial.org                       press@komen.org

SUSAN G. KOMEN ANNOUNCES $27 MILLION HEALTH EQUITY INITIATIVE TO REDUCE BREAST CANCER DEATHS IN AFRICAN-MERICAN COMMUNITY

10-City Initiative Complements Komen’s Decades-Long Service to Medically Under-served

WASHINGTON – Sept. 14, 2016 – The Susan G. Komen breast cancer organization gathered philanthropic, civic, medical and business leaders in Washington today to formally launch a $27 million,10-city initiative to reduce breast cancer death rates among African-American women.

“African-American women are almost 40 percent more likely to die of breast cancer than white women in the U.S. and in some cities, that number is as high as 74 percent. That makes this a public health crisis that must be addressed immediately,” said Komen President and CEO Dr. Judith A. Salerno. “We are deeply appreciative of friends and partners who are working with us to do so.”

Salerno thanked the Fund II Foundation and its president Robert F. Smith for the $27 million grant that made the Komen African-American Health Equity Initiative possible. “This investment in women’s health will truly save lives,” Salerno said.

Smith said at the event today that the breast cancer initiative ties strongly to Fund II’s priorities. “The Reverend Dr. Martin Luther King said that the biggest injustice one can find is really in health care,” he said. “The Fund II Foundation is focused on – among a number of pillars – helping to decrease that disparity and level the playing field in health care and treatment for African-American women.”

Komen’s African-American Health Equity Initiative initially targets 10 U.S. cities where mortality rates and late-stage diagnosis of African-American women are highest. The goal: to reduce the mortality gap by 25 percent within five years of beginning work in each city. The Initiative will expand across the country.

Joining Smith and Salerno were Jeri Lacks Whye, patient advocate and granddaughter of Henrietta Lacks, an African-American woman whose cancer cells were taken without her permission before her death in 1951 and used for research for decades, and Dr. Freda Lewis-Hall, chief medical officer and executive vice president of Pfizer.

The panel today reflected Komen’s collaborative approach to the Health Equity Initiative, an approach Whye called critical. “Community engagement is the foundation that allows you to speak with people suffering from breast cancer disparities,” she said. “It starts a conversation that can lead to real results.”

Lewis-Hall stressed the importance of African-American participation in clinical trials. “Why do more of us need to get involved in clinical trials of potential new breast cancer treatments? Because we have so many great scientific opportunities right now and so many questions. These questions will only be answered for us, by us,” she said.

Today’s formal launch of the African-American Health Equity Initiative comes one day after Komen announced a broader 10-year plan to reduce current U.S. breast cancer deaths by 50 percent in 10 years. Komen’s “Bold Goal” strategy focuses on health equity for all medically underserved individuals, and an enhanced focus on research into aggressive and metastatic breast cancer.

More on the African-American Health Equity Initiative

The initial targeted cities are Memphis, Tenn., St. Louis, Mo., Dallas, Los Angeles, Virginia Beach, Va., Atlanta, Chicago, Houston, Washington, D.C. and Philadelphia. Baltimore and Detroit have been identified as high-priority areas as the program expands over the next year.

The African-American Health Equity Initiative complements the work that Komen and its network of 100 U.S. Affiliates already do to remove barriers to cancer care. Komen and Komen Affiliates support thousands of local programs that provide screenings, treatment assistance, emergency financial aid, medical supplies and living expense for underserved individuals.

The organization has invested more than $2 billion over 34 years for these programs aimed at uninsured, underinsured, and medically vulnerable populations.

“We will never waver from our commitment to remove barriers of language, geography, economics or culture for all people facing this disease. Every woman or man must be able to access and receive high-quality breast health and breast cancer care, and be supported through their treatment and into survivorship,” Salerno said.

Click this link for more on the Susan G. Komen African-American Health Equity Initiative.

For more information on Komen’s Bold Goal, visit komen.org or Komen’s Bold Goal link.

9/13/16 - Komen Sets Bold Goal to Reduce US Breast Cancer Deaths By 50% in 10 Years

FOR IMMEDIATE RELEASE

Local Media Contact: Katie Parker               National Media Contact:    Andrea Rader
Susan G. Komen Memorial Affiliate             Susan G. Komen®
(C)309.922.1462 (W) 309.691.6906             972.855.4382
kparker@komenmemorial.org                       press@komen.org

SUSAN G. KOMEN® SETS BOLD GOAL TO REDUCE U.S. BREAST CANCER DEATHS BY 50 PERCENT IN 10 YEARS

Plan Targets Health Equity for All, Enhanced Research Focus for Most Lethal Breast Cancers

DALLAS – Sept.13, 2016 – The Susan G. Komen® breast cancer organization announced a bold plan today to reduce the nation’s 40,000 breast cancer deaths by 50 percent in 10 years, by improving access to quality and timely cancer care for the underserved and enhancing Komen’s research focus on lethal breast cancers.

“We know that people die of breast cancer for two reasons: a lack of high-quality breast cancer care accessible to everyone, and a lack of treatments for the most aggressive and deadly forms of this disease,” said Dr. Judith A. Salerno, president and CEO of Susan G. Komen. “We are taking direct action designed to solve these problems to reduce breast cancer deaths by half in the U.S. within the next decade.”

$27 Million Advanced for Health Equity

Salerno said today that a private foundation is donating $27 million for a program to significantly reduce what she called the “appalling” difference in death rates between African-American and white women in U.S. cities. African-American women are nearly 40 percent more likely to die of breast cancer than white women; in some cities, that gap is as high as 74 percent.

“This constitutes a public health crisis that must be addressed, first in the cities where these death rates are highest, and then in all areas of the country,” Salerno said.

Komen’s African-American Health Equity Initiative targets 10 metropolitan areas where mortality rates and late-stage diagnosis of African-American women are highest. The goal: to reduce the mortality gap by 25 percent within five years of beginning work in each city.

The initial areas include Memphis, Tenn., St. Louis, Mo., Dallas, Los Angeles, Atlanta, Chicago, Houston, Washington, D.C., Virginia Beach, Va., and Philadelphia. Baltimore and Detroit have been identified as high priority areas as the program expands over the next year.

The African-American Health Equity Initiative supplements the work that Komen and its network of 100 U.S. Affiliates already are doing to remove barriers to cancer care. Komen and Komen Affiliates support thousands of local programs that provide screenings, treatment assistance, emergency financial aid, medical supplies and living expense for underserved individuals.

The organization has invested more than $2 billion over 34 years for these programs aimed at uninsured, under-insured, and medically vulnerable populations.

“We will never waver from our commitment to remove barriers of language, geography, economics or culture for all people facing this disease.  Every woman or man must be able to access and receive high-quality breast health and breast cancer care, be supported through their treatment and into survivorship,” Salerno said.

Research

The second prong of Komen’s plan enhances Komen’s focus on aggressive forms of breast cancer and metastatic disease (stage IV or cancer that has spread to other parts of the body).

As the largest nonprofit funder of breast cancer research (investing more than $920 million since inception), Komen has funded nearly $160 million in metastatic disease research since its founding. Komen has funded another $110 million in research on aggressive forms of breast cancer – such as triple negative, inflammatory breast cancer and hormone-positive forms of breast cancer – that are resistant to standard treatments.

“The majority of breast cancer deaths are from metastatic breast cancer. We also know that aggressive forms of breast cancer are more likely to recur and spread, so we are focusing our efforts in both of these areas,” Salerno said.

The new initiative aims to advance research into new treatments for aggressive and metastatic disease. Komen also will seek to leverage next-generation technology that can detect breast cancer at its very earliest stages to prevent recurrence and metastasis.

Progress to Date

Salerno said Komen’s bold goal builds on the progress of the breast cancer movement since Komen was founded in 1982. “Death rates from breast cancer have declined by 37 percent since 1990. We have more treatments than at any time in our history. We’ve come a very long way from a time when breast cancer couldn’t be discussed publicly. Our new bold goal requires us to take a deeper dive and stretch further to ensure that every woman or man can be told, ‘There is help and hope for you.’”

###

8/30/16 - Metastatic Breast Cancer Project Funding

Watch Video

On August 30, Komen announced a new $375,000 commitment to support innovative work being done in research to advance our understanding of metastatic breast cancer through the Metastatic Breast Cancer (MBC) Project.  To learn more about this investment and the impact of the MBC Project, please check out this video and encourage young metastatic survivors to sign up and make an impact on metastatic breast cancer.  https://www.youtube.com/watch?v=BWyzY9eggI8

7/23/16 - Kroger Central Division Public Affairs Team Receives Outstanding Volunteer Group of the Year Award from Susan G. Komen

See Video

 Komen Award - Kroger (275 x 150)Indianapolis, IN, July 28 – “And the Ribbon goes to…” Kroger Central Division Public Affairs team! Last Saturday, July 23, this Kroger team was recognized as the Outstanding Volunteer Group at the annual Komen Leadership Conference near the Susan G. Komen Headquarters in Dallas, TX, and today we celebrate and honor the team with a celebratory lunch and reception at the Kroger Division Office in Indianapolis, IN.  Kroger has been a committed partner to the Memorial Affiliate for more than 15 years under the leadership of Mr. John Elliott, Public Affairs Manager & Media Spokesman, and Mr. Kevin Kotansky, Public Affairs.

Kroger’s monetary support directly impacts families in Central Illinois through our community grants programs, but they provide so much MORE.  The team promotes and supports employee engagement and community involvement, and they lend support to Komen in the following ways, and MORE:

  • Provides Race registration and advertising opportunities, food, and volunteers for three Races hosted by the Memorial Affiliate (including Springfield, IL where there are no Kroger stores); and two Races for the Central Indiana Affiliate
  • Supports local RFTC teams with neighborhood fundraising
  • Hosts October National Mammography Day Education events in 20+ Central Illinois stores, allowing us to reach women in low income neighborhoods, rural areas and small Central Illinois towns with lifesaving breast health information
  • Provides Board and Race for the Cure committee members in both markets

The Susan G. Komen leadership team shares that “as a grassroots organization, it is important to remember that the work of Susan G. Komen could not be accomplished without tremendous support from our volunteers. The Outstanding Volunteer Group Award recognizes a group composed of four or more individuals who have worked together to benefit the Affiliate. Through their work, significant strides have been made by working as a team. Overall, these volunteers demonstrate dedication, commitment, creativity, initiative and dependability. Their achievements, time, compassion and volunteer spirit serve as benchmarks for all volunteers.”

Kroger is a role model for all Komen sponsors as they encourage participation by all potential partners, even other grocers. John Elliott states that “breast cancer knows no bounds so bring on any grocery partner in your service area. We come along side Komen because of the survivors on our team and those who visit our stores; we welcome all to the table”. CONGRATULATIONS to our Kroger Central Division Public Affairs team!!